We seek an energetic and motivated Scientist II to join our Immuno-Oncology team, which is aiming to redirect the immune system towards tumors by engineering hematopoietic cells in vivo. In this role, you will have the opportunity to explore novel immune cell engineering strategies, with an initial focus on monocytes and macrophages, by in vivo delivery of CARs and other immunomodulatory transgenes to reprogram the immunosuppressive tumor microenvironment. You will be expected to have a strong commitment to experimental work and be an independent thinker that can communicate and interact effectively across various disciplines.

You will join a team of scientists dedicated to moving a novel immunotherapy drug candidate into the clinic. Join us and be part of building a company revolutionizing the reach and access of the curative power of genomic medicines for patients with serious diseases.

Required:

Preferred:

Ensoma is a place where you can ask the big questions. We look at gene therapy today and ask: What if we could eliminate the patient burden? What if we could treat diseases that affect millions? What if we could treat people anywhere around the world?

Ensoma was founded to answer these questions through our Engenious™ platform that can transform the hematopoietic (blood & immune) system with a single treatment. Our Engenious gene therapy platform is the first to precisely engineer any or all hematopoietic and immune cells with a one-time, off-the-shelf in vivo treatment. Engenious therapies have an unmatched capacity to deliver all modern genetic modification tools and set a new standard for versatile cell programming and control across a range of complex diseases. We believe the future of medicine lies within us – and this bigger, bolder vision for gene therapy needs incredible people to make it a reality.

For our team, realizing this vision is personal. Founded and guided by leaders drawn from the top of the cell and gene therapy field, we feel an urgency and passion for our work driven by its potential global impact. 

A meeting at Ensoma is a space where curiosity, trust, authenticity, problem-solving and professional development are celebrated. A career at Ensoma is an opportunity to be part of the team building the future of medicine.

Ensoma is a 5AM Portfolio company supported by top-tier investors, strategic partners, and a passionate team committed to a bold global vision for genomic medicines. Ensoma is headquartered in Boston, Massachusetts and has operations in Copenhagen, Demark. For more information, please visit www.ensoma.com.